Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2020 · 10-Q
Revenue$10.15M$10.15Mno prior Q1 2019 on file Net Income$12.93M$12.93MN/M vs Q1 2019 EPS Diluted$0.45$0.45— vs Q1 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$4,873,544N/M Free Cash Flowderived-$5,429,218N/M Margins · derivedGross margin63.5%
Operating margin-60.2%
Net margin127.4%
ended Dec 31, 2019 · filed Feb 13, 2020 · 44 d after period end